NASDAQ:PPH VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News $97.03 -0.03 (-0.03%) (As of 04:32 PM ET) Add Compare Share Share Today's Range$96.35▼$97.0950-Day Range$90.59▼$99.4352-Week Range$74.05▼$99.51Volume291,886 shsAverage Volume140,337 shsMarket Capitalization$653.98 millionAssets Under Management$716.73 millionDividend Yield1.58%Net Expense Ratio0.36% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get VanEck Pharmaceutical ETF alerts: Email Address About VanEck Pharmaceutical ETF (NASDAQ:PPH)The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.Read More PPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PPH ETF News HeadlinesAugust 14, 2024 | msn.comTeva Pharmaceutical hits a new 52-week highJuly 18, 2024 | seekingalpha.comPPH: A Strong Fund To Play Big PharmaSeptember 10, 2024 | Banyan Hill Publishing (Ad)Kamala’s Promise Will Kill America (Revealed)Kamala’s 3-Word Plan to Destroy America — Are You Prepared? Discover the secret plan that will bankrupt every state and devastate your savings. Don’t wait until it’s too late—find out how to protect your wealth today.May 8, 2024 | msn.comJust Say No to Drugs: 3 Pharma Stocks to AvoidApril 23, 2024 | seekingalpha.comPPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total ReturnsApril 18, 2024 | theglobeandmail.comCanada’s updated guidance on ESG-related investment fund disclosureApril 3, 2024 | msn.comVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328April 1, 2024 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328September 10, 2024 | Banyan Hill Publishing (Ad)Kamala’s Promise Will Kill America (Revealed)Kamala’s 3-Word Plan to Destroy America — Are You Prepared? Discover the secret plan that will bankrupt every state and devastate your savings. Don’t wait until it’s too late—find out how to protect your wealth today.March 7, 2024 | investorplace.comThe Top 3 ETFs to Buy in March 2024See More Headlines Receive PPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Pharmaceutical ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:PPH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$704.51 million Average Daily Volume$129,513.90 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerIMC Options OptionableOptionable Options Volume4 Put Options3 Call Options1 Short Interest1,670,000 shs Miscellaneous Outstanding Shares6,740,000Beta0.72 Creation Unit50,000 Creation Fee$500.00 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Ad Banyan Hill PublishingKamala’s Promise Will Kill America (Revealed)Kamala’s 3-Word Plan to Destroy America — Are You Prepared? Discover the secret plan that will bankrupt every state and devastate your savings. Don’t wait until it’s too late—find out how to protect your wealth today.Get the inside scoop and learn how to protect your savings. VanEck Pharmaceutical ETF ExpensesTypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.49%0.52%Other Expenses0.01%0.33%0.49%0.41%0.54%Total Expense0.36%0.71%0.71%0.63%0.71%Fee Waiver0.00%-0.45%-0.53%-0.33%-0.58%Net Expense0.36%0.61%0.61%0.56%0.59% VanEck Pharmaceutical ETF (PPH) Holdings & ExposureTop 10 PPH HoldingsEli Lilly and Company(NYSE:LLY)Holding Weight: 13.06%Novo Nordisk A/S(NYSE:NVO)Holding Weight: 9.00%Johnson & Johnson(NYSE:JNJ)Holding Weight: 6.25%AbbVie(NYSE:ABBV)Holding Weight: 5.98%Novartis(NYSE:NVS)Holding Weight: 5.31%AstraZeneca(NASDAQ:AZN)Holding Weight: 5.09%Haleon(NYSE:HLN)Holding Weight: 5.02%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 4.99%Sanofi(NASDAQ:SNY)Holding Weight: 4.92%Bristol-Myers Squibb(NYSE:BMY)Holding Weight: 4.81%PPH Sector ExposurePPH Industry ExposureFull Holdings Details Similar ETFsVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQInstitutional OwnershipSanctuary Advisors LLCBought 44,094 shares on 9/5/2024Ownership: 0.654%Cetera Investment AdvisersBought 3,237 shares on 8/22/2024Ownership: 0.437%Northwestern Mutual Wealth Management Co.Bought 2,694 shares on 8/16/2024Ownership: 2.374%Susquehanna International Group LLPBought 4,700 shares on 8/16/2024Ownership: 0.000%Beck Capital Management LLCBought 317 shares on 8/14/2024Ownership: 0.316%View All Institutional Transactions PPH ETF - Frequently Asked Questions How have PPH shares performed this year? VanEck Pharmaceutical ETF's stock was trading at $81.37 on January 1st, 2024. Since then, PPH shares have increased by 19.2% and is now trading at $96.98. View the best growth stocks for 2024 here. What is Bruce Gordon's approval rating as VanEck Pharmaceutical ETF's CEO? 38 employees have rated VanEck Pharmaceutical ETF Chief Executive Officer Bruce Gordon on Glassdoor.com. Bruce Gordon has an approval rating of 98% among the company's employees. This puts Bruce Gordon in the top 20% of approval ratings compared to other CEOs of publicly-traded companies. Who are VanEck Pharmaceutical ETF's major shareholders? Top institutional shareholders of VanEck Pharmaceutical ETF include SG Americas Securities LLC, Thrivent Financial for Lutherans (2.61%), Northwestern Mutual Wealth Management Co. (2.37%) and Prime Capital Investment Advisors LLC (1.99%). How do I buy shares of VanEck Pharmaceutical ETF? Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of VanEck Pharmaceutical ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Pharmaceutical ETF investors own include Bank of America (BAC), Alibaba Group (BABA), AeroVironment (AVAV), Activision Blizzard (ATVI), ARK Innovation ETF (ARKK) and Applied Materials (AMAT). This page (NASDAQ:PPH) was last updated on 9/10/2024 by MarketBeat.com Staff From Our PartnersFREE TRAINING TODAY ➡️ How to profit from 2024 electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredHow to grow a small trading account into a $100k? Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloa...Timothy Sykes | SponsoredKamala’s Promise Will Kill America (Revealed)Kamala’s 3-Word Plan to Destroy America — Are You Prepared? Discover the secret plan that will bankrupt eve...Banyan Hill Publishing | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredThis Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPH Stock Alerts